{
    "nctId": "NCT05816538",
    "briefTitle": "The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks",
    "officialTitle": "The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Paravertebral Block, Pectoralis and Serratus Plane Nerve Blocks, Breast Cancer, Immunologic Suppression, Levobupivacaine",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Change in measured serum cytokines using an ELISA test after PVB.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* quadrantectomy with equilateral axillary lymphadenectomy\n* anesthesia preoperative status (American Society of Anesthesiologists (ASA)) 1 and 2\n\nExclusion Criteria:\n\n* patient rejection\n* ASA\\> 3\n* contraindication for local anesthetic\n* contraindications for planned regional anesthesia and analgesia\n* immunosuppressive therapy including corticosteroids\n* acute infection\n* history of chronic opioid use\n* presence of autoimmune disease\n* obese definite body mass index BMI) greater than 29.9 kg/m2",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}